.
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6..
maslow's ideas deserve to be better understood so they can be developed and built upon. by alex fradera.
if you would like to add a comment, please register or log in
.